Open Orphan (ORPH) is targeting rapid scale-up and profitability in the dynamic European orphan and rare disease consulting sector via acquisitions and organic means. The sector is reported to be growing at circa 11%, double the growth rate of the broader pharma market. The company’s Venn Life Scie
25 Nov 2019
Open Orphan: Leveraging expertise and relationships for growth
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Open Orphan: Leveraging expertise and relationships for growth
hVIVO plc (HVO:LON) | 28.6 0 0.4% | Mkt Cap: 194.6m
- Published:
25 Nov 2019 -
Author:
Emma Ulker -
Pages:
3
Open Orphan (ORPH) is targeting rapid scale-up and profitability in the dynamic European orphan and rare disease consulting sector via acquisitions and organic means. The sector is reported to be growing at circa 11%, double the growth rate of the broader pharma market. The company’s Venn Life Scie